Relx (NYSE:RELX) Sets New 1-Year High – Here’s What Happened

Relx Plc (NYSE:RELX)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $51.09 and last traded at $51.01, with a volume of 34952 shares traded. The stock had previously closed at $50.56.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Redburn Atlantic assumed coverage on Relx in a research report on Wednesday, January 8th. They set a “buy” rating on the stock. StockNews.com assumed coverage on Relx in a report on Wednesday, October 30th. They issued a “hold” rating on the stock.

Relx Trading Up 1.2 %

The business has a 50 day moving average of $47.51 and a 200 day moving average of $47.03. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.42 and a current ratio of 0.48.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. JPMorgan Chase & Co. increased its position in shares of Relx by 14.6% in the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock worth $39,225,000 after acquiring an additional 104,999 shares in the last quarter. CWA Asset Management Group LLC acquired a new position in shares of Relx during the third quarter worth about $548,000. Merit Financial Group LLC purchased a new stake in shares of Relx in the fourth quarter worth about $301,000. International Assets Investment Management LLC acquired a new stake in shares of Relx in the third quarter valued at about $1,268,000. Finally, Franklin Resources Inc. raised its holdings in shares of Relx by 3.3% during the 3rd quarter. Franklin Resources Inc. now owns 18,429 shares of the technology company’s stock valued at $873,000 after buying an additional 588 shares during the period. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.